Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evidence of cancer therapy-induced chronic inflammation in the ovary across multiple species: A potential cause of persistent tissue damage and follicle depletion

Journal of Reproductive Immunology(2022)10.1016/j.jri.2022.103491Source: DataRank Database

Evidence of cancer therapy-induced chronic inflammation in the ovary across multiple species: A potential cause of persistent tissue damage and follicle depletion is a research paper published in Journal of Reproductive Immunology (2022). On theSindex it has a DataRank of 0.416. It has been cited 15 times.

N/A

0.416DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)OA: greenTopics (25)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.416

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (11)

Zaira Carranza,Yi Luan ORCID,Kathleen Busman‐Sahay ORCID,Shally Wolf,Shawn Campbell

Live enrichment

PubMed:35176661 PMC:PMC9224575

National Institutes of Health

Grant: P51OD011092

National Institutes of Health

Grant: R01HD082208

National Institutes of Health

Grant: R01HD45787

National Institutes of Health

Grant: RL5GM118963

National Institutes of Health

Grant: TL4GM118965

National Institutes of Health

Grant: U54HD18185

National Institutes of Health

Grant: UL1GM118964

NIH HHS

Grant: S10 OD025002

NICHD NIH HHS

Grant: R01 HD045787

NICHD NIH HHS

Grant: P30 HD018185

NICHD NIH HHS

Grant: U54 HD018185

National Institutes of Health

Grant: 5TL4GM118965-09

EXITO: Enhancing Cross-disciplinary Infrastructure and Training at Oregon

National Institutes of Health

Grant: 3P51OD011092-55S1

SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER

National Institutes of Health

Grant: 5R01HD045787-03

Pre-clinical Trials for Female Fertility Preservation

National Institutes of Health

Grant: 8RL5GM118963-02

Enhancing Cross Disciplinary Infrastructure and Training at Oregon (EXITO) Research Enrich

National Institutes of Health

Grant: 5UL1GM118964-09

EXITO: Enhancing Cross-disciplinary Infrastructure and Training at Oregon

National Institutes of Health

Grant: 5R01HD082208-07

Anti-Mullerian Hormone Actions to Control Primate Folliculogenesis

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9224575

publisherhttps://api.elsevier.com/content/article/PII:S0165037822000195?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0165037822000195?httpAccept=text/plain

https://doi.org/10.1016/j.jri.2022.103491

https://pubmed.ncbi.nlm.nih.gov/35176661

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

OvaryAnimalsMacaca mulattaHumansMiceNeoplasmsInflammationFemaleAnti-Mullerian Hormone

Keywords

InflammationChemotherapyRadiotherapyOvarian DamageFollicle DepletionAnti-Mullerian HormoneMiceNeoplasmsOvaryAnimalsHumansFemaleMacaca mulatta

Sustainable Development Goals

SDG 3: 3. Good health